Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients

References

• WeiM, YangN, WangF, ZhaoG, GaoH, LiY. Epidemiology of coronavirus disease 2019(COVID-19) caused by SARS-CoV-2. Disaster Med Public Health Prep. 2020;14:1–27.
   Web of Science ®Google Scholar
• Rico-MesaJS, WhiteA, AndersonAS. Outcomes in patients with COVID-19 infection taking ACEI/ARB. Curr Cardiol Rep. 2020;22(5):31. doi:10.1007/s11886-020-01291-432291526
   PubMed Web of Science ®Google Scholar
• VelavanTP, MeyerCG. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278–280. doi:10.1111/tmi.1338332052514
   PubMed Web of Science ®Google Scholar
• XuX, ChenP, WangJ, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Press. 2020;63(3):52.
   Google Scholar
• GeH, WangX, YuanX, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011–1019. doi:10.1007/s10096-020-03874-z32291542
   PubMed Web of Science ®Google Scholar
• WangY, LiuS, LiuH, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73(4):807.32437830
   PubMed Web of Science ®Google Scholar
• CardosoFS, PereiraR, GermanoN. Liver injury in critically ill patients with COVID-19: a case series. Crit Care. 2020;24(1):190. doi:10.1186/s13054-020-02924-432366282
   PubMed Web of Science ®Google Scholar
• ChenP, ZhouB. Clinical Characteristics of COVID-19 in Patients With Liver Injury. Clin Gastroenterol Hepatol. 2020;18(12):2846–2847. doi:10.1016/j.cgh.2020.04.04332407783
   PubMed Web of Science ®Google Scholar
• FanZ, ChenL, LiJ, et al. Clinical Features of COVID-19-related liver functional abnormality. Clin Gastroenterol Hepatol. 2020;18(7):1561–1566. doi:10.1016/j.cgh.2020.04.00232283325
   PubMed Web of Science ®Google Scholar
• XuL, LiuJ, LuM, YangD, ZhengX. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40(5):998–1004. doi:10.1111/liv.1443532170806
   PubMed Web of Science ®Google Scholar
• LiuY, QiFY, WeiL, ChengQL. [Clinical analysis of kidney injury in patients with COVID-19]. Zhonghua Yi Xue Za Zhi. 2020;100:E022. Chinese.
   Google Scholar
• FanelliV, FiorentinoM, CantaluppiV, et al. Acute kidney injury in SARS-CoV-2 infected patients. Crit Care. 2020;24(1):155. doi:10.1186/s13054-020-02872-z32299479
   PubMed Web of Science ®Google Scholar
• PostA, den DeurwaarderESG, BakkerSJL, et al. Kidney Infarction in Patients With COVID-19. Am J Kidney Dis. 2020;76(3):431–435. doi:10.1053/j.ajkd.2020.05.00432479921
   PubMed Web of Science ®Google Scholar
• SuH, YangM, WanC, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219–227. doi:10.1016/j.kint.2020.04.00332327202
   PubMed Web of Science ®Google Scholar
• DonoghueM, HsiehF, BaronasE, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res. 2000;87(5):E1–9. doi:10.1161/01.RES.87.5.e110969042
   PubMed Web of Science ®Google Scholar
• ZhangY, GaoY, QiaoL, WangW, ChenD. Inflammatory response cells during acute respiratory distress syndrome in patients with coronavirus disease 2019 (COVID-19). Ann Intern Med. 2020;173(5):402–404. doi:10.7326/L20-022732282871
   PubMed Web of Science ®Google Scholar
• Taghizadeh-HesaryF, AkbariH. The powerful immune system against powerful COVID-19: a hypothesis. Med Hypotheses. 2020;140:109762. doi:10.1016/j.mehy.2020.10976232388390
   PubMed Web of Science ®Google Scholar
• YonggangZ, BinqingF, XiaohuZ, DongshengW, ChangchengZ. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. National Ence Review. 2020;24:587.
   Google Scholar
• OlryA, MeunierL, DelireB, LarreyD, HorsmansY, Le LouetH. Drug-induced liver injury and COVID-19 Infection: the rules remain the same. Drug Saf. 2020;43(7):615–617. doi:10.1007/s40264-020-00954-z32514859
   PubMed Web of Science ®Google Scholar
• MuhovicD, BojovicJ, BulatovicA, et al. First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19. Liver Int. 2020;40:1901.32478465
   PubMed Web of Science ®Google Scholar
• SiseME, BaggettMV, ShepardJO, StevensJS, RheeEP. Case 17-2020: a 68-year-old man with covid-19 and acute kidney injury. N Engl J Med. 2020;382(22):2147–2156. doi:10.1056/NEJMcpc200241832402156
   PubMed Web of Science ®Google Scholar
• ChenT, WuD, ChenH, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi:10.1136/bmj.m109132217556
   PubMed Web of Science ®Google Scholar
• RismanbafA, ZareiS. Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor. Arch Acad Emerg Med. 2020;8(1):e17.32185369
   PubMed Web of Science ®Google Scholar
• HassaneinM, ThomasG, TaliercioJ. Management of acute kidney injury in COVID-19. Cleve Clin J Med. 2020.
   Google Scholar
• ChengY, LuoR, WangK, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838. doi:10.1016/j.kint.2020.03.00532247631
   PubMed Web of Science ®Google Scholar
• RabbH. Kidney diseases in the time of COVID-19: major challenges to patient care. J Clin Invest. 2020;130(6):2749–2751. doi:10.1172/JCI13887132250968
   PubMed Web of Science ®Google Scholar
• RoncoC, ReisT, Husain-SyedF. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020;8(7):738–742. doi:10.1016/S2213-2600(20)30229-032416769
   PubMed Web of Science ®Google Scholar
• SuTH, KaoJH. The clinical manifestations and management of COVID-19-related liver injury. J Formos Med Assoc. 2020;119(6):1016–1018. doi:10.1016/j.jfma.2020.04.02032345544
   PubMed Web of Science ®Google Scholar
• Barros CamargoL, Quintero MarzolaID, Cárdenas GómezJC, Mendoza DazaLT, Quintana PájaroL. Acute kidney injury associated with COVID-19: another extrapulmonary manifestation. Int Urol Nephrol. 2020;52(7):1403–1404. doi:10.1007/s11255-020-02507-w32468166
   PubMed Web of Science ®Google Scholar
• ZhaoD, YaoF, WangL, et al. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. Clin Infect Dis. 2020.
   Web of Science ®Google Scholar
• HuangC, WangY, LiX, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
   PubMed Web of Science ®Google Scholar
• LiJ, FanJG. Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease. J Clin Transl Hepatol. 2020;8(1):13–17. doi:10.14218/JCTH.2020.0001932274341
   PubMed Web of Science ®Google Scholar
• StaicoMF, ZaffanelloM, Di PietroG, FanosV, MarcialisMA. The kidney in COVID-19: protagonist or figurant?Panminerva Med. 2020.
   Google Scholar
• ZhangS. Novel Coronavirus Infected Pneumonia Treatment Scheme (Trial Seventh Edition) [Z]. Clin Drug Investi. 2020;33:1–6
   Google Scholar
• Office of the State Health and Health Commission OotSAoTCM: Diagnosis and treatment of new coronary pneumonia (Trial Version 7)[EB/OL]; 2020. Available from:http://www.nhc.gov.cn/yz[[J]. Accessed 727, 2021.
   Google Scholar
• YeZ, SongB. Liver injury in COVID-19: diagnosis and associated factors. Liver Int. 2020;40(8):2040–2041. doi:10.1111/liv.1450132359220
   PubMed Web of Science ®Google Scholar
• OttossonF, BacoE, LauritzenPM, RudE. The prevalence and locations of bone metastases using whole-body MRI in treatment-naive intermediate- and high-risk prostate cancer. Eur Radiol. 2020;31:2474.
   Web of Science ®Google Scholar
• YeQ, WangB, MaoJ. The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. J Infect. 2020;80(6):607–613. doi:10.1016/j.jinf.2020.03.03732283152
   PubMed Web of Science ®Google Scholar
• ZhangC, WuZ, LiJW, ZhaoH, WangGQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55(5):105954. doi:10.1016/j.ijantimicag.2020.10595432234467
   PubMed Web of Science ®Google Scholar
• FelsensteinS, HerbertJA, McNamaraPS, HedrichCM. COVID-19Immunology and treatment options. Clin Immunol. 2020;215:108448. doi:10.1016/j.clim.2020.10844832353634
   PubMed Web of Science ®Google Scholar
• LiuF, LiL, XuM, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370. doi:10.1016/j.jcv.2020.10437032344321
   PubMed Web of Science ®Google Scholar
• YangY, ShenC, LiJ, et al. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. 2020;146(1):119–127.e4. doi:10.1016/j.jaci.2020.04.02732360286
   PubMed Web of Science ®Google Scholar
• ZhuZ, CaiT, FanL, et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis. 2020;95:332–339. doi:10.1016/j.ijid.2020.04.04132334118
   PubMed Web of Science ®Google Scholar
• SeowJ, ZhouY, HuaJ, et al. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection. Int J Environ Res Public Health. 2021;18(1):284. doi:10.3390/ijerph18010284
   Web of Science ®Google Scholar
• Amiri-DashatanN, KoushkiM, GhorbaniF, NaderiN. Increased inflammatory markers correlate with liver damage and predict severe COVID-19: a systematic review and meta-analysis. Gastroenterol Hepatol Bed Bench. 2020;13(4):282–291.33244370
   PubMedGoogle Scholar
• ChenLY, ChuHK, BaiT, et al. Liver damage at admission is an independent prognostic factor for COVID-19. J Dig Dis. 2020;21(9):512–518. doi:10.1111/1751-2980.1292532713118
   PubMed Web of Science ®Google Scholar
• KumarA, FaiqMA, PareekV, et al. Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients. Med Hypotheses. 2020;144:110271. doi:10.1016/j.mehy.2020.11027133254575
   PubMed Web of Science ®Google Scholar
• MarjotT, WebbGJ, BarrittA, et al. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2021;18(5):348–364. doi:10.1038/s41575-021-00426-433692570
   PubMed Web of Science ®Google Scholar
• Shokri AfraH, Amiri-DashatanN, GhorbaniF, MalekiI, Rezaei-TaviraniM. Positive association between severity of COVID-19 infection and liver damage: a systematic review and meta-analysis. Gastroenterol Hepatol Bed Bench. 2020;13(4):292–304.33244371
   PubMedGoogle Scholar
• ChenT, DaiZ, MoP, et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. J Gerontol a Biol Sci Med Sci. 2020;75(9):1788–1795. doi:10.1093/gerona/glaa08932279081
   PubMed Web of Science ®Google Scholar
• ZhouF, YuT, DuR, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
   PubMed Web of Science ®Google Scholar
• ZhangJJ, DongX, CaoYY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:10.1111/all.1423832077115
   PubMed Web of Science ®Google Scholar
• GrasselliG, ZangrilloA, ZanellaA, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.539432250385
   PubMed Web of Science ®Google Scholar
• KuklaM, Skonieczna-ZydeckaK, KotfisK, et al. COVID-19, MERS and SARS with concomitant liver injury-systematic review of the existing literature. J Clin Med. 2020;9(5):1420. doi:10.3390/jcm9051420
   PubMed Web of Science ®Google Scholar
• PineiroGJ, Molina-AndujarA, HermidaE, et al. Severe acute kidney injury in critically ill COVID-19 patients. J Nephrol. 2021;45:587.
   Google Scholar
• SangL, ChenS, ZhengX, et al. The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study. BMC Pulm Med. 2020;20(1):290. doi:10.1186/s12890-020-01305-533167955
   PubMed Web of Science ®Google Scholar
• GhosnM, AttallahN, BadrM, et al. Severe Acute Kidney Injury in Critically Ill Patients with COVID-19 Admitted to ICU: incidence, Risk Factors, and Outcomes. J Clin Med. 2021;10(6):1217. doi:10.3390/jcm1006121733804100
   PubMed Web of Science ®Google Scholar
• WanS, XiangY, FangW, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797–806. doi:10.1002/jmv.2578332198776
   PubMed Web of Science ®Google Scholar